Universal Health International Group Holding Limited (HKG:2211)
Hong Kong · Delayed Price · Currency is HKD 0.4600
+0.0200 (4.55%)
Oct 2, 2026, 4:08 PM HKT
HKG:2211 Income Statement
Financials in millions CNY. Fiscal year is July - June.
Millions CNY. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 519.21 | 711.51 | 1,089 | 1,297 | 1,274 | |
Revenue Growth | -27.03% | -34.67% | -16.04% | 1.84% | 7.46% |
Cost of Revenue | 431.41 | 598.12 | 909.15 | 1,083 | 1,069 |
Gross Profit | 87.8 | 113.39 | 179.89 | 213.85 | 204.16 |
Selling, General & Admin | 95.08 | 136.32 | 205.6 | 303.12 | 380.35 |
Other Operating Expenses | -0.93 | -0.36 | -1.81 | -2.88 | -6.46 |
Operating Expenses | 94.14 | 135.96 | 203.79 | 300.24 | 373.89 |
Operating Income | -6.35 | -22.57 | -23.9 | -86.39 | -169.73 |
Interest Expense | -0.84 | -0.95 | -1.36 | -1.27 | -1.17 |
Interest & Investment Income | 0.46 | 0.58 | 0.6 | 0.93 | 2.87 |
Earnings From Equity Investments | - | 0.66 | 1.73 | -20.96 | -1.63 |
Currency Exchange Gain (Loss) | -4.88 | 2.49 | -3.63 | 7.86 | 1.58 |
Other Non Operating Income (Expenses) | -0.15 | -0.18 | -0.21 | -0.24 | -0.15 |
EBT Excluding Unusual Items | -11.76 | -19.97 | -26.78 | -100.07 | -168.22 |
Gain (Loss) on Sale of Investments | - | 1.99 | - | -10.43 | -21.99 |
Gain (Loss) on Sale of Assets | - | 1.95 | 28.14 | -1.93 | 1.79 |
Asset Writedown | -5.26 | -6.9 | -4.16 | 0.34 | 0.41 |
Pretax Income | -17.01 | -22.94 | -2.79 | -112.11 | -188.01 |
Income Tax Expense | 3.42 | 2.73 | -3.37 | -5.99 | - |
Earnings From Continuing Operations | -20.43 | -25.67 | 0.58 | -106.12 | -188.01 |
Minority Interest in Earnings | - | -0.33 | -0.17 | 0.72 | 0.37 |
Net Income | -20.43 | -26.01 | 0.41 | -105.4 | -187.65 |
Net Income to Common | -20.43 | -26.01 | 0.41 | -105.4 | -187.65 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 104 | 80 | 67 | 58 | 44 |
Shares Outstanding (Diluted) | 104 | 80 | 67 | 58 | 44 |
Shares Change | 29.78% | 19.80% | 14.67% | 32.58% | 13.85% |
EPS (Basic) | -0.20 | -0.32 | 0.01 | -1.81 | -4.27 |
EPS (Diluted) | -0.20 | -0.32 | 0.01 | -1.81 | -4.27 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | - | -59.85 | -101.75 | -18.21 | -42.52 |
Free Cash Flow Per Share | - | -0.75 | -1.52 | -0.31 | -0.97 |
Gross Margin | 16.91% | 15.94% | 16.52% | 16.49% | 16.03% |
Operating Margin | -1.22% | -3.17% | -2.20% | -6.66% | -13.33% |
Profit Margin | -3.94% | -3.65% | 0.04% | -8.13% | -14.73% |
Free Cash Flow Margin | - | -8.41% | -9.34% | -1.40% | -3.34% |
EBITDA | 7.23 | -9 | -10.21 | -70.62 | -151.19 |
EBITDA Margin | 1.39% | -1.26% | -0.94% | -5.45% | -11.87% |
D&A For EBITDA | 13.58 | 13.58 | 13.69 | 15.77 | 18.54 |
EBIT | -6.35 | -22.57 | -23.9 | -86.39 | -169.73 |
EBIT Margin | -1.22% | -3.17% | -2.20% | -6.66% | -13.33% |